Leaflet IPERTROFAN 40 150000ui (40mg) gastro-resistant film-coated tablets
Indicated for: benign prostatic hyperplasia
Route of administration: oral
Substance: mepartricin (polyene antibiotic)
ATC: G04CX03 (Genito urinary system and sex hormones | Drugs used in benign prostatic hypertrophy | Other drugs used in benign prostatic hypertrophy)
Dose adjustment may be needed in kidney disease.
Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.
Seek medical advice if severe or persistent diarrhea occurs.
Mepartricin is a medication primarily used for the treatment of benign prostatic hyperplasia and certain inflammatory conditions of the urinary tract. It works by reducing inflammation and improving urinary flow.
The drug has anti-inflammatory and anti-estrogenic properties, making it useful in alleviating symptoms associated with prostate enlargement, such as difficulty urinating or the sensation of incomplete bladder emptying.
Mepartricin is administered orally, usually in capsule form, and the duration of treatment depends on the severity of the condition. It is important to follow the doctor's instructions to achieve the best results.
Adverse effects are rare but may include gastrointestinal disturbances or allergic reactions. Patients with hypersensitivity to this medication should avoid its use.
General data about IPERTROFAN 40 150000ui (40mg)
- Substance: mepartricin
- Date of latest medicines list: 01-07-2015
- Product code: W04114002
- Concentration: 150000ui (40mg)
- Pharmaceutical form: gastro-resistant film-coated tablets
- Quantity: 20
- Product type: Original
- Prescription status: P-6L - Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.